By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Octapharma invests EUR 142 million in its Viennese facility

Barbara Rangetiner, Octapharma (Mitte) © APA Juhasz

Following two and a half years of construction, the company opened a new research and development center offering modern and secure jobs to more than 100 highly qualified employees at a cost of EUR 23.5 million. As a result, Octapharma strengthened Vienna’s status as a Group-wide center for research and development. In addition, construction work will be completed this year on a new pilot plant located at the site. This production line comprises the link between research work and routine production. Investments in the pilot plant amount to EUR 39.5 million. Simultaneously with the opening of the R&D center, Octapharma carried out the groundbreaking ceremony for its third major investment, namely a new production building involving investments of EUR 79 million. It will enable a doubling of production capacities by the year 2026. Total investments for all three projects amount to EUR 142 million.  

 “With these investments we profess our commitment to the Vienna business location, with which we are linked by a long tradition. In addition to the R&D center, one of the most modern production plants in the world will be built, thus creating many high-quality jobs”, explains Barbara Rangetiner, General Manager of Octapharma Pharmazeutika. The company, which has been operating in Vienna since 1989, specializes in the development and manufacturing of products derived from human proteins, and is the world’s largest family-owned supplier in this field.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Austria Oportunidades de negocio en el marco actual

    23. September 2020/ 10:00 - 11:15, Online Conference

  • China Global Investment Summit 2020

    24.09. - 25.09. 2020, Shenzen, China

Austria Map

Find the perfect location for your company

Vienna’s unique location at the heart of Europe makes it an important centre and very popular with the global pharmaceutical and biotechnology industry. Vienna is where Eastern Europe meets Western Europe. Businesses located at this international hub benefit from well-established infrastructures and highly-qualified professionals. The significant growth in the Life Sciences sector in Vienna over the last few years is an indicator of the momentum in the industry.

ABF Pharmaceutical Services

ABF Pharmaceutical Services
More testimonials

news from the business location Austria

Investment for augmented reality startup Amlogy

Augmented reality (AR) has always been a passion for Arkadi Jeghiazaryan.

Support measures for companies affected by COVID-19

To stimulate the economy, either new programs may be established as a result of the draft law or existing support programs (e.g. aws, ÖHT) will be expanded. All measures introduced are intended to be applicable immediately and will be in force until the end of 2020. The measures currently introduced include the following areas:

More news All blog posts